Answer
Evidence is limited. It should only be considered after specialist assessment of exposure risk, gestational age and possible fetal or neonatal risks.
Sources for this answer
- IXCHIQ Chikungunya vaccine (live)emc · SmPC Current selected SmPC · Version 1